In order to overcome the challenges associated with a limited number of airway epithelial cells that can be obtained from clinical sampling and their restrained capacity to divide ex vivo, miniaturization of respiratory drug discovery assays is of pivotal importance. Thus, a 96-well microplate system was developed where primary human small airway epithelial (hSAE) cells were cultured at an air–liquid interface (ALI). After four weeks of ALI culture, a pseudostratified epithelium containing basal, club, goblet and ciliated cells was produced. The 96-well ALI cultures displayed a cellular composition, ciliary beating frequency, and intercellular tight junctions similar to 24-well conditions. A novel custom-made device for 96-parallelized transepithelial electric resistance (TEER) measurements, together with dextran permeability measurements, confirmed that the 96-well culture developed a tight barrier function during ALI differentiation. 96-well hSAE cultures were responsive to transforming growth factor β1 (TGF-β1) and tumor necrosis factor α (TNF-α) in a concentration dependent manner. Thus, the miniaturized cellular model system enables the recapitulation of a physiologically responsive, differentiated small airway epithelium, and a robotic integration provides a medium throughput approach towards pharmaceutical drug discovery, for instance, in respect of fibrotic distal airway/lung diseases.
In order to circumvent the limited access and donor variability of human primary alveolar cells, directed differentiation of human pluripotent stem cells (hiPSCs) into alveolar-like cells, provides a promising tool for respiratory disease modeling and drug discovery assays. In this work, a unique, miniaturized 96-Transwell microplate system is described where hiPSC-derived alveolar-like cells were cultured at an air–liquid interface (ALI). To this end, hiPSCs were differentiated into lung epithelial progenitor cells (LPCs) and subsequently matured into a functional alveolar type 2 (AT2)-like epithelium with monolayer-like morphology. AT2-like cells cultured at the physiological ALI conditions displayed characteristics of AT2 cells with classical alveolar surfactant protein expressions and lamellar-body like structures. The integrity of the epithelial barriers between the AT2-like cells was confirmed by applying a custom-made device for 96-parallelized transepithelial electric resistance (TEER) measurements. In order to generate an IPF disease-like phenotype in vitro, the functional AT2-like cells were stimulated with cytokines and growth factors present in the alveolar tissue of IPF patients. The cytokines stimulated the secretion of pro-fibrotic biomarker proteins both on the mRNA (messenger ribonucleic acid) and protein level. Thus, the hiPSC-derived and cellular model system enables the recapitulation of certain IPF hallmarks, while paving the route towards a miniaturized medium throughput approach of pharmaceutical drug discovery.
Macrophages play a pivotal role in drug discovery due to their key regulatory functions in health and disease. Overcoming the limited availability and donor variability of human monocyte-derived macrophages (MDMs), human induced pluripotent stem cell (iPSC)-derived macrophages (IDMs) could provide a promising tool for both disease modeling and drug discovery. To access large numbers of model cells for medium- to high-throughput application purposes, an upscaled protocol was established for differentiation of iPSCs into progenitor cells and subsequent maturation into functional macrophages. These IDM cells resembled MDMs both with respect to surface marker expression and phago- as well as efferocytotic function. A statistically robust high-content-imaging assay was developed to quantify the efferocytosis rate of IDMs and MDMs allowing for measurements both in the 384- and 1536-well microplate format. Validating the applicability of the assay, inhibitors of spleen tyrosine kinase (Syk) were shown to modulate efferocytosis in IDMs and MDMs with comparable pharmacology. The miniaturized cellular assay with the upscaled provision of macrophages opens new routes to pharmaceutical drug discovery in the context of efferocytosis-modulating substances.
Human macrophages differ from their mouse counterparts in multiple metabolic pathways, surface protein expression, and transcription factor biology. Monocyte-derived macrophages (MDMs) from blood are generally used to study human macrophage biology in vitro. However, the use of MDMs as a human macrophage model is limited by donor-to-donor variability, total cell availability, preactivation effects, and relative resistance to genetic manipulation. Here, we explored stem cell–derived macrophages to study in vitro disease-relevant macrophage phenotypes. We compared induced pluripotent stem cell–derived macrophages (iDMs) with primary human stem cell–derived macrophages from cord blood–derived macrophages or bone marrow–derived macrophages (BMDMs) in their ability to elaborate tissue and disease-relevant phenotypes in comparison with conventional blood MDMs. Analyses of phenotypical and functional features revealed that iDMs were highly similar to cord blood–derived macrophages and BMDMs, and resembled MDMs. Importantly, all macrophages, and particularly iDMs adopted expected disease-relevant phenotypes in vitro when stimulated with disease-associated mediators. RNA sequencing analyses of in vitro macrophages stimulated with tissue relevant factors revealed that their transcriptomes mapped to human in vivo inflammatory conditions. Using this approach, we found a close correlation between stimulation and expected disease-association counterpart in vivo. In conclusion, we established a streamlined system to link stem cell–derived macrophage phenotypes to relevant macrophage phenotypes in disease states. Thus, enabling conditions for in vitro replication of complex human macrophage biology observed in single-cell RNA sequencing from human diseased tissue.
Macrophage polarization critically contributes to a multitude of human pathologies. Hence, modulating macrophage polarization is a promising approach with enormous therapeutic potential. Macrophages are characterized by a remarkable functional and phenotypic plasticity, with pro-inflammatory (M1) and anti-inflammatory (M2) states at the extremes of a multidimensional polarization spectrum. Cell morphology is a major indicator for macrophage activation, describing M1(-like) (rounded) and M2(-like) (elongated) states by different cell shapes. Here, we introduced cell painting of macrophages to better reflect their multifaceted plasticity and associated phenotypes beyond the rigid dichotomous M1/M2 classification. Using high-content imaging, we established deep learning- and feature-based cell painting image analysis tools to elucidate cellular fingerprints that inform about subtle phenotypes of human blood monocyte-derived and iPSC-derived macrophages that are characterized as screening surrogate. Moreover, we show that cell painting feature profiling is suitable for identifying inter-donor variance to describe the relevance of the morphology feature ‘cell roundness’ and dissect distinct macrophage polarization signatures after stimulation with known biological or small-molecule modulators of macrophage (re-)polarization. Our novel established AI-fueled cell painting analysis tools provide a resource for high-content-based drug screening and candidate profiling, which set the stage for identifying novel modulators for macrophage (re-)polarization in health and disease.
Disease-associated macrophage states contribute to the pathogenesis of numerous inflammatory disorders. While small molecule-mediated macrophage repolarization represents a promising strategy to restore homeostasis, current approaches often rely on predefined molecular markers and may therefore overlook previously unrecognized modulators of macrophage plasticity. To address this limitation, we performed a phenotypic high-content cell painting screen in induced pluripotent stem cell-derived and blood monocyte-derived macrophages. Using our previously established machine learning-based cell painting analysis pipeline, we screened the annotated opnMe and JUMP-CP compound libraries and identified 26 compounds that induced M1- or M2-like polarization phenotypes. Among these hits, we identified WZ4003, an inhibitor of AMPK-related kinases NUAK1 and NUAK2, as novel macrophage-polarizing compound. Combining cell painting feature profiling with functional analyses, we revealed that the NUAK1/2 inhibitor WZ4003 induces a distinct macrophage state characterized by a rounded M1-like morphology, ferroptosis protection, mitochondrial reactive oxygen species increase, antioxidative adaptation, and phagocytosis and efferocytosis impairment. These findings link specific morphological signatures to functional macrophage states. Overall, this study provides a resource of macrophage-polarizing compounds and demonstrates the utility of machine learning-based cell painting for identifying novel modulators of macrophage polarization states.